XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.1
Marketable Securities
3 Months Ended
Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities Marketable Securities
All of the Company's marketable securities were available-for-sale and were classified based on their maturities. Marketable securities with remaining maturities at the date of purchase of three months or less are classified as cash equivalents. Short term investments are securities that original maturity or remaining maturity is greater than three months and not more than twelve months. Long-term investments are securities for which the original maturity or remaining maturity is greater than twelve months.

The table below summarizes the marketable securities:
March 31, 2020
Amortized CostUnrealized GainsUnrealized LossesAggregate Fair Value
(in thousands)
Money market funds$62,194  $—  $—  $62,194  
Cash equivalents62,194  —  —  62,194  
U.S. treasury securities52,025  323  —  52,348  
Corporate bonds11,816   (47) 11,773  
Commercial paper13,252  —  —  13,252  
Short-term investments77,093  327  (47) 77,373  
Corporate bonds1,278  —  (4) 1,274  
Long-term investments1,278  —  (4) 1,274  
Total marketable securities$140,565  $327  $(51) $140,841  

December 31, 2019
Amortized CostUnrealized GainsUnrealized LossesAggregate Fair Value
(in thousands)
Money market funds$3,068  $—  $—  $3,068  
Commercial paper2,495  —  —  2,495  
Cash equivalents5,563  —  —  5,563  
U.S. treasury securities67,051  34  (2) 67,083  
Corporate bonds9,075  24  (2) 9,097  
Commercial paper5,165  —  —  5,165  
Short-term investments81,291  58  (4) 81,345  
Corporate bonds1,278  —  —  1,278  
Long-term investments1,278  —  —  1,278  
Total marketable securities$88,132  $58  $(4) $88,186  
The long-term investments outstanding as of March 31, 2020 and December 31, 2019 mature in April 2021.
Unrealized gains and losses on available-for-sale securities are recorded in accumulated other comprehensive income (loss) on the condensed consolidated balance sheets. The Company evaluates its investments to assess whether those in unrealized loss positions are other-than-temporarily impaired. The Company considers impairments to be other-than-temporary if it is related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of their cost basis. The Company did not identify any of its marketable securities as other-than-temporarily impaired as of March 31, 2020 and December 31, 2019.